发明授权
US6030969A 5,6,7-trisubstituted-4-aminopyrido[2,3-D] pyrimidine compounds
失效
5,6,7-三取代-4-氨基吡啶并[2,3-D]嘧啶化合物
- 专利标题： 5,6,7-trisubstituted-4-aminopyrido[2,3-D] pyrimidine compounds
- 专利标题（中）： 5,6,7-三取代-4-氨基吡啶并[2,3-D]嘧啶化合物
-
申请号： US58324申请日： 1998-04-09
-
公开(公告)号： US6030969A公开(公告)日： 2000-02-29
- 发明人: Shripad S. Bhagwat , Richard J. Perner , Yu-Gui Gu
- 申请人： Shripad S. Bhagwat , Richard J. Perner , Yu-Gui Gu
- 申请人地址： IL Abbot Park
- 专利权人： Abbott Laboratories
- 当前专利权人： Abbott Laboratories
- 当前专利权人地址： IL Abbot Park
- 主分类号： C07D471/04
- IPC分类号： C07D471/04 ; A61K31/505
摘要：
A compound having the formula ##STR1## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4 and R.sup.5 are defined, a method for inhibiting adenosine kinase by administering a compound thereof, a pharmaceutical composition comprising a therapeutically effective amount of a compound thereof above in combination with a pharmaceutically acceptable carrier, a method of treating cerebral ischemia, epilepsy, pain, nociperception, inflammation and sepsis in a mammal in need of such treatment, comprising administering to the mammal a therapeutically effective amount of a compound thereof, and methods for preparation thereof.
公开/授权文献
- USD387343S Keyboard 公开/授权日：1997-12-09
信息查询
